<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01508754</url>
  </required_header>
  <id_info>
    <org_study_id>FINEP-01.08.0615.00</org_study_id>
    <nct_id>NCT01508754</nct_id>
  </id_info>
  <brief_title>Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome</brief_title>
  <official_title>Efficacy of Continuous Positive Airway Pressure (CPAP) on Blood Pressure Control of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome (OSAS).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Financiadora de Estudos e Projetos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to evaluate the effect of treatment with Continuous Positive Airway Pressure
      (CPAP) device on clinic and ambulatory blood pressures (BP) of 200 resistant hypertensive
      patients with moderate-severe obstructive sleep apnea syndrome (OSAS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea syndromes (OSAS) have been demonstrated to be highly prevalent in
      patients with resistant hypertension (defined as uncontrolled clinic BP despite being on
      anti-hypertensive treatment with at least 3 drugs in optimal doses and including a diuretic).
      Nevertheless, the effect of treating OSAS with Continuous Positive Airway Pressure (CPAP)
      device on clinic and ambulatory BPs in patients with resistant hypertension is largely
      unknown. Hence, the primary aim of this randomized clinical trial is to evaluate the effect
      of CPAP on BP levels in resistant hypertensive patients with moderate-severe OSAS (defined as
      an apnea-hypopnea index [AHI] greater than 15 on a full polysomnographic examination).
      Two-hundred patients will be randomly allocated either to treatment with CPAP device plus
      their usual anti-hypertensive treatment or to continue their usual treatment alone for 6
      months. Clinic and 24-hour ambulatory BP monitoring, laboratory evaluation (including
      microalbuminuria and aldosterone-to-renin ratio), 24-hour Holter monitoring, ergospirometric
      treadmill test, and carotid-femoral pulse wave velocity measurement will be performed before
      and after the 6-month treatment, with the observers blinded to the allocation group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinic and ambulatory blood pressures</measure>
    <time_frame>6 months</time_frame>
    <description>Clinic and ambulatory blood pressures (during 24-hour ambulatory blood pressure monitoring, which included both daytime and nighttime blood pressures, as well as the nocturnal dipping pattern).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microalbuminuria</measure>
    <time_frame>6 months</time_frame>
    <description>Urinary albumin excretion rate on 24-hour urine collection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone excess measurements</measure>
    <time_frame>6 months</time_frame>
    <description>Serum aldosterone concentration, plasma renin activity, aldosterone-to-renin ratio and 24-hour urinary aldosterone excretion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial stiffness</measure>
    <time_frame>6 months</time_frame>
    <description>Carotid-femoral pulse wave velocity and aortic pulse wave contour analysis (which include aortic systolic and pulse pressure and augmentation index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomic system measurements</measure>
    <time_frame>6 months</time_frame>
    <description>Measures of autonomic system balance derived from 24-hour Holter monitoring, which includes heart rate variability on time and frequency domains.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory fitness</measure>
    <time_frame>6 months</time_frame>
    <description>Cardiorespiratory fitness by 6 min walking test with maximum oxigen consumption measurement and by complete ergospirometric treadmill test.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <condition>Resistant Hypertension</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with Continuous Positive Airway Pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual anti-hypertensive treatment without CPAP treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous positive airway pressure treatment</intervention_name>
    <description>Treatment with CPAP for 6 months, pressure will be titrated during a second polysomnography.</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with resistant hypertension and moderate-severe obstructive sleep apnea
             syndrome

        Exclusion Criteria:

          -  Older than 80 years

          -  Pregnant women

          -  Non-adherent to anti-hypertensive treatment

          -  Severe cognitive deficits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gil F Salles, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine, Faculty of Medicine, federal University of Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Program of Arterial Hypertension, University Hospital Clementino Fraga Filho</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>21941-913</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.prohart.hucff.ufrj.br</url>
  </link>
  <reference>
    <citation>Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension. 2004 Mar;43(3):518-24. Epub 2004 Jan 19.</citation>
    <PMID>14732721</PMID>
  </reference>
  <reference>
    <citation>Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001 Dec;19(12):2271-7.</citation>
    <PMID>11725173</PMID>
  </reference>
  <reference>
    <citation>Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep. 2001 Sep 15;24(6):721-5.</citation>
    <PMID>11560187</PMID>
  </reference>
  <reference>
    <citation>Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, Ryan CF, Fleetham J, Choi P, Ayas NT. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007 Mar-Apr;185(2):67-72. Epub 2007 Mar 28.</citation>
    <PMID>17393240</PMID>
  </reference>
  <reference>
    <citation>Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, Velkeniers B. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007 Apr 23;167(8):757-64.</citation>
    <PMID>17452537</PMID>
  </reference>
  <reference>
    <citation>Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F; Spanish Sleep and Breathing Group. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010 Nov 24;341:c5991. doi: 10.1136/bmj.c5991.</citation>
    <PMID>21106625</PMID>
  </reference>
  <reference>
    <citation>Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, Espinel E, Ríos J, Untoria MD, Lloberes P. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens. 2010 Oct;28(10):2161-8. doi: 10.1097/HJH.0b013e32833b9c63.</citation>
    <PMID>20577130</PMID>
  </reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2012</study_first_submitted>
  <study_first_submitted_qc>January 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2012</study_first_posted>
  <last_update_submitted>September 12, 2014</last_update_submitted>
  <last_update_submitted_qc>September 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Gil Fernando da Costa Mendes de Salles, PhD</investigator_full_name>
    <investigator_title>Full Professor, Faculty of Medicine</investigator_title>
  </responsible_party>
  <keyword>Continuous positive airway pressure</keyword>
  <keyword>Ambulatory blood pressures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

